Pharmaceutical products entering international markets must meet the applicable regulatory requirements of their destination countries. LIHI Pharma supports regulatory-related enquiries by coordinating with relevant manufacturing partners, suppliers, and regulatory service providers, where applicable. Our focus is on facilitating access to relevant product information and documentation required for pharmaceutical trading, exports, and market-specific requirements.
Regulatory requirements may vary according to the product, dosage form, country, and intended use. Documentation, registration status, and submission requirements are therefore assessed on a case-by-case basis. Any regulatory submission, approval, or certification remains subject to the relevant authorities and responsible parties.
LIHI Pharma aims to simplify communication between customers and relevant pharmaceutical partners by coordinating product information and applicable documentation enquiries. The availability and scope of regulatory support depend on the product, destination market, and services provided by the responsible partners. Regulatory approvals and market authorizations are granted only by the relevant competent authorities.